Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests to detect cancers early by measuring enzyme activity.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Urteste S.A. is a research and development company specializing in innovative in vitro diagnostic (IVD) medical devices. The company focuses on creating a pioneering technology for the early detection of multiple types of cancer from a single, non-invasive urine sample. Its proprietary method is based on measuring the activity of specific enzymes to identify malignancies at an early stage, with the goal of substantially increasing patient survival rates. The company's development pipeline includes diagnostic tests for various cancers, such as the Panuri Test for pancreatic cancer and a test for breast cancer.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 17:38
Audit Report / Information
Opinia biegłego
Polish 366.5 KB
2025-09-29 17:38
Management Discussion and Analysis
Sprawozdanie z działalności Zarządu za I półrocze 2025
Polish 1.0 MB
2025-09-29 17:38
Interim Report
Sprawozdanie finansowe za I półrocze 2025
Polish 1.2 MB
2025-08-05 16:08
Report Publication Announcement
Uzyskanie ochrony patentowej od Urzędu Patentowego Rzeczypospolitej Polskiej na…
Polish 1.2 KB
2025-08-01 15:12
Board/Management Information
BIO - Przemysław Mencel
Polish 117.1 KB
2025-08-01 15:12
Board/Management Information
Powołanie Członka Rady Nadzorczej - Content (PL)
Polish 1.2 KB
2025-07-31 20:13
Board/Management Information
Rezygnacja Członka Rady Nadzorczej - Content (PL)
Polish 446 bytes
2025-07-25 13:21
Regulatory News Service
Zawarcie umowy z firmą BIOTYPE GmbH na produkcję testu Panuri - Content (PL)
Polish 1.9 KB
2025-06-30 11:20
Regulatory News Service
Przyznanie ochrony patentowej od Urzędu Patentowego w Indonezji na wynalazek w …
Polish 913 bytes
2025-06-26 11:19
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 1.4 KB
2025-06-25 18:17
Board/Management Information
Życiorysy Członków RN
Polish 57.1 KB
2025-06-25 18:17
Post-Annual General Meeting Information
Powołanie członków Rady Nadzorczej Emitenta na nową kadencję - Content (PL)
Polish 1.3 KB
2025-06-25 17:22
Post-Annual General Meeting Information
Uchwały ZWZ
Polish 252.3 KB
2025-06-25 17:22
Post-Annual General Meeting Information
Treść uchwał podjętych podczas obrad Zwyczajnego Walnego Zgromadzenia w dniu 25…
Polish 655 bytes
2025-06-23 08:42
Regulatory News Service
Zakończenie prac rozwojowych i osiągnięcie gotowości technologicznej do rozpocz…
Polish 3.0 KB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel NRGN
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland OCS
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM

Talk to a Data Expert

Have a question? We'll get back to you promptly.